Cat Vaccine Industry Growth Insights: Revenue Forecast to 2030

January 28, 2026January 28, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the artificial intelligence (ai)-driven hospital readmission predictor market from 2026–2035 with trusted insights from The Business Research Company

What are the forecasted starting (2026) and ending (2030) market sizes for the Cat Vaccine Market?

The cat vaccine market size has experienced strong growth in recent years. It is anticipated to expand from $1.26 billion in 2025 to $1.38 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.2%. This historical growth can be attributed to several factors including an increasing incidence of feline infectious diseases, the constrained availability of advanced vaccines, a rise in pet ownership, the expansion of veterinary clinics, and government-initiated vaccination programs.

The cat vaccine market is projected to demonstrate significant expansion over the coming years. This market is forecast to reach $1.93 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.9%. The growth anticipated during this period stems from technological progress in vaccine creation, a rising need for recombinant and DNA vaccines, increased understanding of preventive pet healthcare, the expansion of online veterinary offerings, and the incorporation of AI and data analytics into disease tracking. Prominent trends expected include a greater uptake of core vaccination protocols, the burgeoning use of recombinant and DNA vaccines, wider availability of veterinary healthcare services, enhanced public knowledge of pet well-being and illness prevention, and the integration of telemedicine and remote monitoring in animal care.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20526&type=smp

What Drivers Are Supporting Technological Adoption In The Cat Vaccine Market?

The expanding occurrence of zoonotic diseases is anticipated to drive the demand in the cat vaccine market moving forward. These diseases are defined as infections transmissible from animals to humans, caused by various pathogens like bacteria, viruses, fungi, or parasites. Their spread can occur via direct contact, vectors, or polluted surroundings, with common examples including lyme disease, rabies, toxoplasmosis, salmonellosis, and brucellosis. The rise in zoonotic disease prevalence is attributed to factors such as climate change, antibiotic resistance, and both legal and illicit wildlife trade. Cat vaccines play a crucial role in managing these diseases by lessening the chance of transmission from felines to humans, specifically by immunizing cats against conditions like toxoplasmosis and cat scratch fever. This forward-looking method assists in lessening the health implications of zoonotic diseases for humans, backs public health initiatives, and guarantees a safer habitat for companion animals and their owners. As an illustration, in February 2024, a report from the Government of the United Kingdom indicated that England recorded 335 confirmed cases of Lyme disease in the fourth quarter of 2023, which was an increase from 273 cases observed in the corresponding period of 2022. Consequently, the growing incidence of zoonotic diseases is a key factor propelling the cat vaccine market.

What Segment Types Are Examined In The Cat Vaccine Market?

The cat vaccine market covered in this report is segmented –

1) By Vaccine Type: Modified Or Attenuated Live, Inactivated, Other Vaccine Types

2) By Disease Type: Feline Leukemia, Feline Panleukopenia, Feline Respiratory Diseases, Feline Rabies, Other Disease Types

3) By Technology: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Deoxyribonucleic Acid (DNA) Vaccines, Recombinant Vaccines

4) By Route Of Administration: Injectables, Intranasal, Oral

5) By Distribution Channel: Veterinary Clinics, Pet Stores, Online Retailers

Subsegments:

1) By Modified Or Attenuated Live: Feline Viral Rhinotracheitis (FVR) Vaccine, Feline Calicivirus (FCV) Vaccine, Feline Panleukopenia (FPV) Vaccine

2) By Inactivated: Inactivated Feline Leukemia Virus (FeLV) Vaccine, Inactivated Feline Infectious Peritonitis (FIP) Vaccine

3) By Other Vaccine Types: Recombinant Vaccines, DNA Vaccines, Subunit Vaccines, Combination Vaccines

Which Trends Are Shaping Activity Within The Cat Vaccine Market?

Leading companies within the cat vaccine market are focusing on the creation of innovative offerings, such as NOBIVAC NXT vaccines, which incorporate advanced Ribonucleic acid (RNA)-particle technology to boost immune responses, improve vaccine effectiveness, and provide specific defense against feline diseases. This cutting-edge Ribonucleic acid (RNA)-particle technology represents a novel method that utilizes RNA molecules enclosed within nanoparticles to deliver genetic instructions to cells, prompting them to generate particular proteins that trigger a precise immune reaction. For example, in June 2024, MSD Animal Health Inc., a US-based pharmaceutical company, launched The NOBIVAC NXT Rabies portfolio, featuring NOBIVAC NXT Feline-3 Rabies and NOBIVAC NXT Canine-3 Rabies, a comprehensive vaccination solution designed to offer robust protection against rabies in both cats and dogs. The NOBIVAC NXT vaccines are formulated without adjuvants and preservatives, thus enhancing their safety profile while maintaining efficacy. These vaccines stimulate both humoral (antibody-mediated) and cell-mediated immune responses, ensuring extensive protection against the rabies virus.

Who Are The Top-Performing Companies In The Cat Vaccine Market In Recent Years?

Major companies operating in the cat vaccine market are Merck & Co. Inc., Boehringer Ingelheim International GmbH, Zoetis Inc., MSD Animal Health, Elanco Animal Health Incorporated, Ceva Santé Animale, Virbac, HIPRA Corporation, Bioveta AS, Biogénesis Bagó SA, Torigen Pharmaceuticals Inc., Vetoquinol SA, Phibro Animal Health Corporation, IDT Biologika GmbH, Vaxxinova BV, Colorado Serum Company, Huvepharma NV, Bimeda Biologicals, CAVAC, Kyoto Biken Laboratories, Avimex Animal Health, Ringpu Biology, Wuhan Keqian Biology, Pulike Biological Engineering, Chengdu Kanghua Biological Products, Yebio, FATRO

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/cat-vaccine-global-market-report

Which Region Currently Holds The Largest Share Of The Cat Vaccine Market?

North America was the largest region in the cat vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cat vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Cat Vaccine Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20526&type=smp

Browse Through More Reports Similar to the Global Cat Vaccine Market 2026, By The Business Research Company

Animal Drug Compounding Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/animal-drug-compounding-global-market-report

Animal Wound Care Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/animal-wound-care-global-market-report

Animal Disinfectants Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/animal-disinfectants-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795